Inventor · disambiguated record
Chikateru Nozaki
Also filed as: NOZAKI CHIKATERU
33 granted patents·16 pending applications·763 citations·filing 1984–2016
97Inventor score
Files withCHEMO SERO THERAPEUT RES INST23ISIS PHARMACEUTICALS INC6MATSUDA JUNICHI3NOZAKI CHIKATERU2BABA MASANORI1
Top patents by PatentIndex Score
49 records- 0195US6174868B1Compositions and methods for treatment of hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1997·Granted Jan 16, 2001·141 cites·11 claims
- 0292US7361748B2von Willebrand factor (vWF)—cleaving proteaseCHEMO SERO THERAPEUT RES INST·Filed 2005·Granted Apr 22, 2008·11 cites·4 claims
- 0391US7112666B2Von Willebrand Factor (Vwf)-cleaving proteaseCHEMO SERO THERAPEUT RES INST·Filed 2002·Granted Sep 26, 2006·24 cites·5 claims
- 0490US8067221B2Von Willebrand factor (vWF)-cleaving proteaseSOEJIMA KENJI·Filed 2008·Granted Nov 29, 2011·7 cites·6 claims
- 0590US6608191B1Compositions and methods for treatment of hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 2000·Granted Aug 19, 2003·34 cites·4 claims
- 0690US6423489B1Compositions and methods for treatment of Hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1995·Granted Jul 23, 2002·120 cites·7 claims
- 0787US6284458B1Compositions and methods for treatment of hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1993·Granted Sep 4, 2001·87 cites·6 claims
- 0886US8883165B2Modified peptide vaccine derived from influenza M2KAMINAKA KAZUYOSHI·Filed 2010·Granted Nov 11, 2014·6 cites·10 claims
- 0986US7575872B2Antibody against von Willebrand factor cleaving enzyme and assay system using the sameCHEMO SERO THERAPEUT RES INST·Filed 2003·Granted Aug 18, 2009·15 cites·8 claims
- 1086US6995146B2Compositions and methods for treatment of hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 2001·Granted Feb 7, 2006·26 cites·8 claims
- 1183US8106015B2Method for enhancing immune response with peptideMATSUDA JUNICHI·Filed 2008·Granted Jan 31, 2012·5 cites·21 claims
- 1283US6391542B1Compositions and methods for treatment of Hepatitis C virus-associated diseasesISIS PHARMACEUTICALS INC·Filed 1996·Granted May 21, 2002·95 cites·8 claims
- 1382US7704951B2Method for ameliorating dyskinesiaCHEMO SERO THERAPEUT RES INST·Filed 2008·Granted Apr 27, 2010·7 cites·9 claims
- 1480US5024938ARecombinant DNA inserted with hepatitis B virus gene, mammalian cells transformed with cloned viral DNA, and production of hepatitis B virus proteinsCHEMO SERO THERAPEUT RES INST·Filed 1986·Granted Jun 18, 1991·55 cites·8 claims
- 1578US4778761ARecombinant plasmid inserted with hepatitis B virus gene, yeast transformed with said recombinant plasmid, and production of hepatitis B virus surface antigenCHEMO SERO THERAPEUT RES INST·Filed 1987·Granted Oct 18, 1988·42 cites·2 claims
- 1674US4997767AYeast shuttle vectorCHEMO SERO THERAPEUT RES INST·Filed 1986·Granted Mar 5, 1991·34 cites·4 claims
- 1771US8512709B2Modified amyloid β peptideMATSUDA JUNICHI·Filed 2009·Granted Aug 20, 2013·1 cites·18 claims
- 1869US8043629B2Bioabsorbable synthetic nonwoven fabric holding thrombinCHEMO SERO THERAPEUT RES INST·Filed 2007·Granted Oct 25, 2011·1 cites·8 claims
- 1969US7960508B2Peptide having cytotoxicity inhibitory activity and method of screening these peptide having cytotoxicity inhibitory activityCHEMO SERO THERAPEUT RES INST·Filed 2002·Granted Jun 14, 2011·1 cites·20 claims
- 2064US7598349B2Antibodies to peptide fragments having cell death-inhibitory activityCHEMO SERO THERAPEUT RES INST·Filed 2005·Granted Oct 6, 2009·0 cites·4 claims
- 2162US8940306B2Method for enhancing immune response with peptideCHEMO SERO THERAPEUT RES INST·Filed 2013·Granted Jan 27, 2015·0 cites·19 claims
- 2261US2014343248A1Method for enhancing immune response with peptideCHEMO SERO THERAPEUT RES INST·Filed 2014·Application pending·0 cites
- 2359US9028463B2Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle deviceNOZAKI CHIKATERU·Filed 2009·Granted May 12, 2015·3 cites·9 claims
- 2459US5059538ARecombinant plasmid inserted with herpes simplex virus geneCHEMO SERO THERAPEUT RES INST·Filed 1986·Granted Oct 22, 1991·17 cites·2 claims
- 2559US2007249534A1Novel medicament for treating neurodegenerative diseasesHIRASHIMA MASAKI·Filed 2007·Application pending·0 cites
- 2658US2013041137A1von Willebrand Factor (vWF) - Cleaving ProteaseCHEMO SERO THERAPEUT RES INST·Filed 2011·Application pending·0 cites
- 2757US8623374B2Method for enhancing immune response with peptideMATSUDA JUNICHI·Filed 2011·Granted Jan 7, 2014·0 cites·8 claims
- 2857US2008153132A1Genetic recombinant ecarin and process for preparing the sameCHEMO SERO THERAPEUT RES INST·Filed 2007·Application pending·0 cites
- 2953US5811260AExogenous gene expression vector containing chick β-actin gene promoterCHEMO SERO THERAPEUT RES INST·Filed 1989·Granted Sep 22, 1998·9 cites·11 claims
- 3053US2005164365A1Genetically modified ecarin and process for producing the sameCHEMO SERO THERAPEUT RES INST·Filed 2002·Application pending·0 cites
- 3153US2004033978A1Compositions and methods for treatment of Hepatitis C virus-associated diseasesFiled 2003·Application pending·0 cites
- 3252US9114098B2Method for using inactivated Japanese encephalitis virus particles as adjuvantMORIYAMA MAKOTO·Filed 2009·Granted Aug 25, 2015·0 cites·16 claims
- 3351US9381242B2Adjuvant composition containing citrullineNOZAKI CHIKATERU·Filed 2012·Granted Jul 5, 2016·0 cites·20 claims
- 3449US10556005B2Adjuvant composition containing citrullineTHE CHEMO SERO THERAPEUTIC RES INSTITUTE·Filed 2016·Granted Feb 11, 2020·0 cites·2 claims
- 3548US5770400AExogenous gene expression vector containing chick β-actin gene promoterCHEMO SERO THERAPEUT RES INST·Filed 1997·Granted Jun 23, 1998·7 cites·11 claims
- 3648US2004049021A1Compositions and mehtods for treatment of Hepatitis C virus-associated diseasesFiled 2003·Application pending·0 cites
- 3745US7199097B1Peptide fragments having cell death inhibitory activityCHEMO SERO THERAPEUT RES INST·Filed 1999·Granted Apr 3, 2007·7 cites·5 claims
- 3843US2010113338A1Prophylactic or therapeutic agent for corneal/conjunctival diseaseKOWA CO·Filed 2006·Application pending·0 cites
- 3943US2007224251A1Hemostatic materialTANIHARA MASAO·Filed 2006·Application pending·0 cites
- 4042US4612283AMethod for purification of HBs antigenCHEMO SERO THERAPEUT RES INST·Filed 1984·Granted Sep 16, 1986·8 cites·14 claims
- 4142US2004131620A1Human polyclonal antibody compositionsFiled 2002·Application pending·0 cites
- 4242US2005037954A1Novel agents for ameliorating motor disorderFiled 2001·Application pending·0 cites
- 4341US7635577B2Process for producing human thrombin by gene modification techniqueCHEMO SERO THERAPEUT RES INST·Filed 2002·Granted Dec 22, 2009·0 cites·7 claims
- 4441US2007117180A1Enzyme producing plasma protein fragment having inhibitory activity to metastasis and growth of cancer and plasma protein fragment produced by fragmentation by said enzymeMORIKAWA WATARU·Filed 2006·Application pending·0 cites
- 4541US2005143310A1Novel remedies for neurodegenerative diseaseFiled 2002·Application pending·0 cites
- 4641US2006051851A1Novel selenocysteine-containing proteinKAMINAKA SARA·Filed 2002·Application pending·0 cites
- 4739US8853354B2Polyion complex comprising hydrophobized polyamino acid and use of the sameBABA MASANORI·Filed 2010·Granted Oct 7, 2014·0 cites·21 claims
- 4839US2006127460A1Trombin-carrying bioabsorbable synthetic nonwoven fabricCHEMO SERO THERAPEUT RES INST·Filed 2003·Application pending·0 cites
- 4937US2006024322A1Novel prophylactics/remedies for immunopathyCHEMO SERO THERAPEUT RES INST·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →